A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy or more complex care.
The study, led by researchers at RCSI University of Medicine and Health Sciences, is published in the June edition of Psychosomatic Medicine.
This is the first systematic review to compare treatments for depression in those with coronary disease and the findings provide valuable clinical information to help doctors determine the best treatment plan for patients.
The researchers reviewed treatment trials which investigated antidepressants, psychotherapy, exercise, combined psychotherapy and antidepressants, and collaborative care (i.e. treatments devised by a multidisciplinary team of clinicians with input from the patient).
To measure effectiveness, the researchers looked at factors including patient adherence to the treatment (dropout rate) and change in depressive symptoms eight weeks after commencing treatment.
The strongest treatment effects were found to be exercise and combination treatments (antidepressants and psychotherapy). However, as the combination study results have a high risk of bias, the findings of the review suggest that exercise is probably the most effective treatment. Antidepressants had the most research support, while psychotherapy and collaborative care did not perform very well.
Release date: 08 Jun 2021
Source: RCSI
Link Between Gut Microbes and Stroke
New findings from Cleveland Clinic researchers show for the first time that the gut microbiome impacts stroke severity and functional impairment following stroke. The results, published in Cell Host & Microbe, lay the groundwork for potential new interventions to help treat or prevent stroke.
In this study we found that dietary choline and TMAO produced greater stroke size and severity, and poorer outcomes in animal models. Remarkably, simply transplanting gut microbes capable of making TMAO was enough to cause a profound change in stroke severity.
The researchers compared brain damage in preclinical stroke models between those with elevated or reduced TMAO levels. Over time, those with higher levels of TMAO had more extensive brain damage and a greater degree of motor and cognitive functional deficits following stroke. The researchers also found that dietary changes that alter TMAO levels, such as eating less red meat and eggs, impacted stroke severity.
Release date: 16 Jun 2021
Source: Cleveland Clinic
Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
Metformin works by lowering glucose production in the liver, reducing blood sugar levels that, in turn, improve the body’s response to insulin. But scientists have also noted that metformin possesses anti-inflammatory properties, though the basis for this activity was not known.
In a study published in the journal Immunity, a multi-institution team led by researchers at University of California San Diego School of Medicine identified the molecular mechanism for the anti-inflammatory activity of metformin and, in mouse studies, found that metformin prevents pulmonary or lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.
Release date: 08 Jun 2021
Source: University of California – San Diego
Air pollution exposure during pregnancy may boost babies’ obesity risk
Women exposed to higher levels of air pollution during pregnancy have babies who grow unusually fast in the first months after birth, putting on excess fat that puts them at risk of obesity and related diseases later in life, new CU Boulder research shows.
The study of Hispanic mother-child pairs, published this week in the journal Environmental Health, is the latest to suggest that poor air quality may contribute at least in part to the nation’s obesity epidemic, particularly among minority populations who tend to live in places with more exposure to toxic pollutants.
About one in four Hispanic youth in the United States are obese, compared to about 14% of white youth and 11% of Asian youth.
Release date: 10 Jun 2021
Source: University of Colorado at Boulder
COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment
A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer’s Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer’s, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.
Reports of neurological complications in COVID-19 patients and “long-hauler” patients whose symptoms persist after the infection clears are becoming more common, suggesting that SARS-CoV-2 (the virus that causes COVID-19) may have lasting effects on brain function. However, it is not yet well understood how the virus leads to neurological issues.
Release date: 10 Jun 2021
Source: Cleveland Clinic
Vitamin D deficiency may increase risk for addiction to opioids and ultraviolet rays
Lab animals deficient in vitamin D crave and become dependent on opioids, which is curbed when normal levels of the vitamin are restored.
Human health records indicate that people with low vitamin D are more likely to use and misuse opioids.
Study results suggest a potential role for vitamin D supplementation in fighting opioid addiction.
Vitamin D deficiency strongly exaggerates the craving for and effects of opioids, potentially increasing the risk for dependence and addiction, according to a new study led by researchers at Massachusetts General Hospital (MGH). These findings, published in Science Advances, suggest that addressing the common problem of vitamin D deficiency with inexpensive supplements could play a part in combating the ongoing scourge of opioid addiction.
Release date: 11 Jun 2021
Source: Massachusetts General Hospital
COVID-19 Reinfection Rate Less Than 1% for Those with Severe Illness
A review of more than 9,000 U.S. patients with severe COVID-19 infection showed less than 1% contracted the illness again, with an average reinfection time of 3.5 months after an initial positive test.
The researchers teamed up with the MU Institute for Data Science and Informatics and the Tiger Institute for Health Innovation to review data from 62 U.S. health care facilities. They found 63 of the 9,119 patients (0.7%) with severe COVID-19 infection contracted the virus a second time, with a mean reinfection period of 116 days. Of the 63 who were reinfected, two (3.2%) died. Patients categorized as non-white were at greater risk of reinfection than white patients.
Their study, “Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing,” was recently published in the journal Clinical Infectious Diseases.
Release date: 15 Jun 2021
Source: University of Missouri-Columbia
Women’s mental health has higher association with dietary factors
Women’s mental health likely has a higher association with dietary factors than men’s, according to new research from Binghamton University.
Lina Begdache, assistant professor of health and wellness studies at Binghamton University, had previously published research on diet and mood that suggests that a high-quality diet improves mental health. She wanted to test whether customization of diet improves mood among men and women ages 30 or older.
Fast food, skipping breakfast, caffeine and high-glycemic (HG) food are all associated with mental distress in mature women,” said Begdache. “Fruits and dark green leafy vegetables (DGLV) are associated with mental well-being. The extra information we learned from this study is that exercise significantly reduced the negative association of HG food and fast food with mental distress,” said Begadache.
The paper, “Customization of Diet May Promote Exercise and Improve Mental Wellbeing in Mature Adults: The Role of Exercise as a Mediator,” was published in the Journal of Personalized Medicine .
Release date: 07 Jun 2021
Source: Binghamton University
Exercise likely to be best treatment for depression in coronary heart disease
A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy or more complex care.
The study, led by researchers at RCSI University of Medicine and Health Sciences, is published in the June edition of Psychosomatic Medicine.
This is the first systematic review to compare treatments for depression in those with coronary disease and the findings provide valuable clinical information to help doctors determine the best treatment plan for patients.
The researchers reviewed treatment trials which investigated antidepressants, psychotherapy, exercise, combined psychotherapy and antidepressants, and collaborative care (i.e. treatments devised by a multidisciplinary team of clinicians with input from the patient).
To measure effectiveness, the researchers looked at factors including patient adherence to the treatment (dropout rate) and change in depressive symptoms eight weeks after commencing treatment.
The strongest treatment effects were found to be exercise and combination treatments (antidepressants and psychotherapy). However, as the combination study results have a high risk of bias, the findings of the review suggest that exercise is probably the most effective treatment. Antidepressants had the most research support, while psychotherapy and collaborative care did not perform very well.
Release date: 08 Jun 2021
Source: RCSI
People who have trouble sleeping are at a higher risk of dying – especially people with diabetes
In a paper published by the Journal of Sleep Research, researchers reveal how they examined data from half a million middle-aged UK participants asked if they had trouble falling asleep at night or woke up in the middle of the night.
The report found that people with frequent sleep problems are at a higher risk of dying than those without sleep problems. This grave outcome was more pronounced for people with Type-2 diabetes: during the nine years of the research, the study found that they were 87 per cent more likely to die of any cause than people without diabetes or sleep disturbances.
The study also found that people with diabetes and sleep problems were 12 per cent more likely to die over this period than those who had diabetes but not frequent sleep disturbances.
Release date: 08 Jun 2021
Source: University of Surrey
Motor neurons derived from patients point to new possible drug target for ALS
Amyotrophic lateral sclerosis (ALS) is a severe, fatal neurodegenerative disorder causing loss of motor neurons and voluntary muscle action. While mouse studies have identified potential treatments, these drugs have typically done very poorly in human trials. Researchers at Boston Children’s Hospital, working in collaboration with Pfizer, now report a high-throughput target and drug discovery platform using motor neurons made from ALS patients. Using the platform, they confirmed two known targets and identified an existing class of drugs — agonists to the dopamine D2 receptor — as potential novel treatments.
The researchers, led by Clifford Woolf, MD, PhD, director of the F.M. Kirby Neurobiology Center at Boston Children’s, and first authors Xuan Huang, PhD, and Kasper Roet, PhD, in Woolf’s lab, describe the platform and their findings June 8 in the journal Cell Reports .
To create the motor neurons used for drug screening, the team used induced pluripotent stem cells, made by the lab of Kevin Eggan at Harvard University from tissue samples of patients with ALS who carried the SOD1(A4V) mutation. The Woolf lab also developed a high-throughput, live-cell imaging technology to measure the motor neurons’ hyperexcitability — the tendency to “fire” excessively — before and after exposure to candidate drugs. Woolf and colleagues previously showed that human motor neurons with ALS mutations are more excitable than normal motor neurons.
Release date: 08 Jun 2021
Source: Boston Children’s Hospital